摘要
报告肝动脉插管化疗、栓塞治疗１０３例中医辨证具有血淤证症状的原发性肝癌患者。其中治疗组３９例加服参莲胶囊一个疗程以上，与对照组６４例比较结果：治疗组血淤证症状改善，肝区疼痛、腹胀、舌紫暗、苔黄根厚腻这几项均 Ｐ＜０． ０５；化疗药物引起的毒副反应减轻，白细胞Ⅰ度、血小板Ⅰ度、ＡＬＴ ０度、恶心呕吐Ⅰ度较多且均 Ｐ＜０． ０５。生活质量有所提高，用 Ｋａｒｎａｔａｋｙ计分，８０～７０分的明显增多（ Ｐ＜０． ０５）。可见，以参莲胶囊配合介入治疗具有血没证症状的原发性肝癌患者方证合拍，值得应用．
patients with primary carcinorna of liver were treated by hepatic arterial catheterization and embolization methods,and 39 patients of them took Shenlian capsule at same time. After a course the patients symptoms were obviously improved such as the abdominal fullness. hepatalgia and so on,tokic and side reaction induced by chemotherapeutic drug were markedly lowered,living quality was increased. According to the karnataky counting 80~70 fen in Shenlian capsule group was higher than that of the control group (P<0. 05). It is suggested that the interrenient method plus Shenlian capsule for the patients with primary carcinoma of liver are superior in many respeCts to only useing intervehient method and are worth spreading.
关键词
原发性
肝癌
参莲胶囊
介入疗法
Primary cartinoma of liver Intervenient treatment Shenlian capsule
